Podcast: Why neuroscience is the ‘final frontier’

Listen as specialists from Merck discuss what they’re most excited about in researching potential treatments for neurologic disorders

July 11, 2023

Share this article


Group photo

Our scientists are revolutionizing how we discover and develop treatments to address unmet medical needs in a number of areas, including neuroscience.

“It’s sort of like the final frontier,” said Joe Herring, scientific AVP, clinical research, in our new podcast. “You’re going off into space to try to figure out how to do very difficult things.”

For more, listen in as Herring sits down with Merck clinical research team senior principal scientists Yuki Mukai and Ari Merola as well as business development director Paige Lacatena to explore today’s breakthroughs and challenges in the field of neuroscience.

Listen to the podcast

Read the full transcript

Explore careers in R&D at Merck

Man and women scientists in a lab


Are you interested in a career in R&D?